LQDALiquidia Corporation Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 18168
Ticker: LQDA
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2018-07-26
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: LQDA

Detail

Enriched 2026-08-14 20:47

Market cap: $7,052,405,521.89
Shares outstanding (class): 88,928,099
Shares outstanding (weighted): 89,508,891
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 216
Location: MORRISVILLE, NC
Homepage: https://www.liquidia.com
Description: Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Market cap and share counts drift.

Funds holding this security

97 funds · 97 positions · $296.07M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$78.72M	0.00%	2,085,778 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$60.33M	0.08%	1,598,666 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$28.89M	0.04%	765,402 NS	FIGI
iShares Russell 2000 Growth ETF iShares Trust	IWO	$20.14M	0.17%	533,577 NS	FIGI
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC.	—	$9.84M	0.09%	260,626 NS	FIGI
T. Rowe Price Integrated U.S. Small-Cap Growth … T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC.	—	$8.48M	0.10%	224,600 NS	FIGI
State Street(R) SPDR(R) S&P Kensho New Economie… SPDR SERIES TRUST	KOMP	$8.35M	0.36%	221,156 NS	FIGI
Fidelity Enhanced Small Cap ETF Fidelity Covington Trust	FESM	$7.62M	0.19%	201,985 NS	FIGI
iShares U.S. Pharmaceuticals ETF iShares Trust	IHE	$7.25M	0.72%	192,090 NS	FIGI
T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC.	—	$6.58M	0.05%	174,300 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$6.23M	0.51%	165,080 NS	FIGI
State Street(R) SPDR(R) S&P(R) Pharmaceuticals … SPDR SERIES TRUST	XPH	$5.78M	1.88%	153,099 NS	FIGI
Bridge Builder Small/Mid Cap Growth Fund Bridge Builder Trust	—	$4.83M	0.05%	127,993 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$3.97M	0.08%	105,258 NS	FIGI
iShares Core S&P Total U.S. Stock Market ETF iShares Trust	ITOT	$3.41M	0.00%	90,310 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERLQDA
FIGI_COMPOSITEBBG001J2P905
FIGI_SHARE_CLASSBBG001V0GFD7
CIK0001819576
ISINUS53635D2027
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Liquidia Corporation is a pharmaceutical company, as indicated by its SIC code 2834 for pharmaceutical preparations.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.